Altfest L J & CO Inc Arcutis Biotherapeutics, Inc. Transaction History
Altfest L J & CO Inc
- $692 Million
- Q4 2024
A detailed history of Altfest L J & CO Inc transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Altfest L J & CO Inc holds 14,455 shares of ARQT stock, worth $164,787. This represents 0.03% of its overall portfolio holdings.
Number of Shares
14,455
Previous 14,408
0.33%
Holding current value
$164,787
Previous $134,000
50.0%
% of portfolio
0.03%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding ARQT
# of Institutions
206Shares Held
130MCall Options Held
738KPut Options Held
82K-
Jennison Associates LLC12.3MShares$141 Million0.11% of portfolio
-
Rubric Capital Management LP New York, NY11MShares$125 Million2.84% of portfolio
-
Suvretta Capital Management, LLC New York, NY10.7MShares$122 Million3.92% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$100 Million4.4% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$98.3 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $686M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...